THE POLICY PROGNOSIS | GLP-1s: Consumer Weight Loss, or Exacerbated Insurer Costs?

Hoya | Georgetown University

Sep 22, 2026

Glucagon-like peptide-1 (GLP-1) receptor agonists, which signal the pancreas to release insulin solely when blood sugar is high, are both a common treatment for type 2 diabetes, an…